2013
Session 1
- Affordable Care Act and the Healthcare Marketplace (2nd PDF Here)
Gregory R. Dill- Practicing at the Top of your Profession
Phil Burgess, RPh, MBA- Patient Protection & Affordable Care Act (PPACA)
Jenelle Sobotka, B.S., Pharm.D., FAPhASession 2
- Important Considerations for the Introduction of Biosimilars in the U.S.
Frank A. Scappaticci, MD, PhD- Biosimilars and the PPACA: Clinical Considerations and Educational Needs
Christopher J. Topoleski- Biosimilars: The Impact on Academic Pharmacy
George E. MacKinnon III, PhD, MS, RPh, FASHP- Biosimilars: A Pharmacy Benefit Manager (PBM) Perspective
R. FalkenrathSession 3
- Providing Innovative Health Care Delivery Utilizing Pharmacists: Medication Therapy Management Services Update
Marialice S. Bennett, RPh, FAPhA- Caring for Indigent Patients: Opportunities in a Health Care Reform Environment”
Yolanda Hardy, PharmD- 340B Partnerships
Sandra F. Durley, PharmD- Caring for Indigent Patients: Opportunities for Pharmacists in a Health Care Reform Environment
Christie Schumacher, PharmD, BCPS, BC-ADM, CDESession 4
- Clinical Community Pharmacists
Beverly Schaefer, RPh- Innovative Ways to Utilize Medication Therapy Management
Jim Gartner RPh, MBA- Patient Protection & Affordable Care Act: Collaborative Practice & Its Impact – Proactivity and Reactivity
Edward Langston, RPh, MD